Acadian Asset Management
ZURA icon

Acadian Asset Management’s Zura Bio ZURA Stock Holding History

Acadian Asset Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52,040
Closed -$271K – 2278
2025
Q4 		$271K Sell
52,040
-13,860
-21% -$54.8K ﹤0.01% 1458
2025
Q3 		$285K Buy
65,900
+21,038
+47% +$37.8K ﹤0.01% 1335
2025
Q2 		$46K Buy
+44,862
New +$53.6K ﹤0.01% 1495

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Acadian Asset Management's ZURA Position: Q1 2026 in Review

Acadian Asset Management sold out of Zura Bio (ZURA) in Q1 2026, closing a stake of 52,040 shares — an estimated $271K sold.

Acadian Asset Management first reported a position in ZURA in Q2 2025 and held it in 3 quarters. The position peaked at $285K in Q3 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Acadian Asset Management reported no remaining Zura Bio position as of Q1 2026 after selling out during the quarter.
  • Acadian Asset Management sold 52,040 Zura Bio shares in Q1 2026, an estimated $271K.
  • Acadian Asset Management first reported a position in Zura Bio in Q2 2025 and held it in 3 quarters.
  • Acadian Asset Management's Zura Bio position peaked at $285K in Q3 2025.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.